Literature DB >> 17131774

XDR-TB: entering the post-antibiotic era?

Mario Raviglione.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 17131774

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN： 1027-3719            Impact factor:   2.373


× No keyword cloud information.
  34 in total

1.  Tuberculosis and its future management.

Authors:  John C Moore-Gillon
Journal:  Thorax       Date:  2007-12       Impact factor: 9.139

Review 2.  Doomsday postponed? Preventing and reversing epidemics of drug-resistant tuberculosis.

Authors:  Christopher Dye
Journal:  Nat Rev Microbiol       Date:  2009-01       Impact factor: 60.633

3.  Apocalypse or redemption: responding to extensively drug-resistant tuberculosis.

Authors:  Ross Upshur; Jerome Singh; Nathan Ford
Journal:  Bull World Health Organ       Date:  2009-06       Impact factor: 9.408

4.  The political and ethical challenge of multi-drug resistant tuberculosis.

Authors:  Chris Degeling; Christopher Mayes; Wendy Lipworth; Ian Kerridge; Ross Upshur
Journal:  J Bioeth Inq       Date:  2015-01-29       Impact factor: 1.352

Review 5.  New agents for the treatment of drug-resistant Mycobacterium tuberculosis.

Authors:  Daniel T Hoagland; Jiuyu Liu; Robin B Lee; Richard E Lee
Journal:  Adv Drug Deliv Rev       Date:  2016-05-02       Impact factor: 15.470

6.  Estimating the magnitude and direction of bias in tuberculosis drug resistance surveys conducted only in the public sector: a simulation study.

Authors:  Ted Cohen; Bethany L Hedt; Marcello Pagano
Journal:  BMC Public Health       Date:  2010-06-21       Impact factor: 3.295

7.  Intranasal vaccination with messenger RNA as a new approach in gene therapy: use against tuberculosis.

Authors:  Julio C C Lorenzi; Ana P F Trombone; Carolina D Rocha; Luciana P Almeida; Ricardo L Lousada; Thiago Malardo; Isabela C Fontoura; Renata A M Rossetti; Ana F Gembre; Aristóbolo M Silva; Celio L Silva; Arlete A M Coelho-Castelo
Journal:  BMC Biotechnol       Date:  2010-10-20       Impact factor: 2.563

8.  Performance of the MTBDRsl assay in Georgia.

Authors:  N Tukvadze; N Bablishvili; R Apsindzelashvili; H M Blumberg; R R Kempker
Journal:  Int J Tuberc Lung Dis       Date:  2014-02       Impact factor: 2.373

9.  Genetic evaluation of relationship between mutations in rpoB and resistance of Mycobacterium tuberculosis to rifampin.

Authors:  Anna Zaczek; Anna Brzostek; Ewa Augustynowicz-Kopec; Zofia Zwolska; Jaroslaw Dziadek
Journal:  BMC Microbiol       Date:  2009-01-15       Impact factor: 3.605

10.  Infection control and the burden of tuberculosis infection and disease in health care workers in china: a cross-sectional study.

Authors:  Guang Xue He; Susan van denHof; Marieke J van der Werf; Guo Jie Wang; Shi Wen Ma; Dong Yang Zhao; Yuan Lian Hu; Shi Cheng Yu; Martien W Borgdorff
Journal:  BMC Infect Dis       Date:  2010-10-28       Impact factor: 3.090
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.